Xvivo Perfusion AB (0RKL) Share Forecast & Price Target
0RKL Analyst Ratings
There are no analyst ratings in the last 3 months.
0RKL Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | SEK 240→SEK 225 | hold | 8.38%Upside | Reiterated | 10/24/26 | ||
| Google Medical - Devices | TipRanks - Google | SEK 242→SEK 222 | hold | 6.94%Upside | Reiterated | 10/24/26 | ||
| Anthropic Medical - Devices | TipRanks - Anthropic | SEK 236→SEK 219 | hold | 5.49%Upside | Reiterated | 10/24/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | SEK 241→SEK 220 | hold | 5.97%Upside | Reiterated | 10/24/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | SEK 246→SEK 222 | hold | 6.94%Upside | Downgraded | 10/24/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | SEK 244→SEK 220 | hold | 5.97%Upside | Reiterated | 10/24/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 10/24/26 | SEK 240→SEK 225 | hold | 8.38%Upside | Reiterated | TipRanks - PerPlexity | ||
| Google Medical - Devices | 10/24/26 | SEK 242→SEK 222 | hold | 6.94%Upside | Reiterated | TipRanks - Google | ||
| Anthropic Medical - Devices | 10/24/26 | SEK 236→SEK 219 | hold | 5.49%Upside | Reiterated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 10/24/26 | SEK 241→SEK 220 | hold | 5.97%Upside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 10/24/26 | SEK 246→SEK 222 | hold | 6.94%Upside | Downgraded | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 10/24/26 | SEK 244→SEK 220 | hold | 5.97%Upside | Reiterated | TipRanks - xAI |
Stocks with the Highest Top Analyst Consensus in the General Sector
0RKL Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, 0RKL has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0RKL average Analyst price target in the past 3 months is ―.
0RKL Financial Forecast
HighSEK 1.17
ConsensusSEK 0.87
LowSEK 0.67
0RKL Earnings Forecast
Next quarter’s earnings estimate for 0RKL is SEK 0.87 with a range of SEK 0.67 to SEK 1.17. The previous quarter’s EPS was SEK 1.41. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
HighSEK 284M
ConsensusSEK 262M
LowSEK 245M
0RKL Sales Forecast
Next quarter’s sales forecast for 0RKL is SEK 261.63M with a range of SEK 244.90M to SEK 284.00M. The previous quarter’s sales results were SEK 252.56M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
0RKL Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Xvivo Perfusion AB?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Xvivo Perfusion AB?
To buy shares of GB:0RKL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
